Product NDC: | 51004-1051 |
Proprietary Name: | LIDOCAINE |
Non Proprietary Name: | Lidocaine Hydrochloride and Epinephrine Bitartrate |
Active Ingredient(s): | .01; 20 mg/mL; mg/mL & nbsp; Lidocaine Hydrochloride and Epinephrine Bitartrate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51004-1051 |
Labeler Name: | Novocol Pharmaceutical of Canada, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088390 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111107 |
Package NDC: | 51004-1051-5 |
Package Description: | 50 CARTRIDGE in 1 CARTON (51004-1051-5) > 1.7 mL in 1 CARTRIDGE |
NDC Code | 51004-1051-5 |
Proprietary Name | LIDOCAINE |
Package Description | 50 CARTRIDGE in 1 CARTON (51004-1051-5) > 1.7 mL in 1 CARTRIDGE |
Product NDC | 51004-1051 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lidocaine Hydrochloride and Epinephrine Bitartrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20111107 |
Marketing Category Name | ANDA |
Labeler Name | Novocol Pharmaceutical of Canada, Inc. |
Substance Name | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE |
Strength Number | .01; 20 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |